Free shipping on all orders over $ 500

GluR Glutamate receptor

Cat.No.  Name Information
M2767 Ifenprodil Tartrate Ifenprodil is an atypical noncompetitive antagonist at the NMDA receptor, it interacts with high affinity at a homogeneous population of NMDA receptors in neonatal rat forebrain with IC50 of 0.3 μM.
M9566 Glycine Glycine is an inhibitory neurotransmitter in the CNS and also acts as a co-agonist along with glutamate.
M2884 NMDA NMDA(N-Methyl-D-aspartic acid)is a specific agonist for NMDA receptor mimicking the action of glutamate, the neurotransmitter which normally acts at that receptor.
M3003 CB-839 Telaglenastat (CB-839) is a potent, selective, and orally bioavailable glutaminase inhibitor with IC50 of 24 nM for recombinant human GAC.
M5078 (S)-Willardiine (S)-Willardiine is a potent agonist of AMPA/kainate receptors with EC50 of 44.8 uM.
M5076 ZK200775 hydrate ZK200775 hydrate is a highly selective AMPA/kainate antagonist with little activity against NMDA; have Ki values of 3.2 nM, 100 nM, and 8.5 μM against quisqualate, kainate, and NMDA, respectively.
M5071 ZK200775 ZK200775 is a highly selective AMPA/kainate antagonist with little activity against NMDA; have Ki values of 3.2 nM, 100 nM, and 8.5 μM against quisqualate, kainate, and NMDA, respectively.
M4957 CIQ CIQ is a subunit-selective potentiator of NMDA receptors containing the NR2C or NR2D subunit.
M4956 L-701324 L-701324 is a long-acting oral anticonvulsant compound with high affinity and selectivity for glycine sites on NMDA receptors.
M4950 Topiramate Topiramate is an anticonvulsant that antagonizes GluR5 receptors and acts as a positive allosteric modulator of GABA receptor-mediated currents.
M4833 Eliprodil Eliprodil is a non-competitive NR2B-NMDA receptor antagonist(IC50=1 uM), less potent for NR2A- and NR2C-containing receptors(IC50> 100 uM).
M3904 Pulchinenoside A Pulchinenoside can inhibit abnormal proliferation of synovial membrane by modulating Wnt pathway of RA rats.Pulchinenoside may inhibit the FLS proliferation in AA rats by increase in FLS apoptosis.
M3806 GLYX-13 GLYX-13 is a selective weak partial agonist of the glycine site of the NMDA receptor.
M3445 ADX-47273 ADX47273 is a potent and specific mGlu5 positive allosteric modulator(PAM) with EC50 of 0.17 μM, showing no activity at other mGlu subtypes.
M3279 GYKI-52466 GYKI-52466 is a non-competitive AMPA/kainate antagonists with IC50 of 7.5 μM and 11 μM, respectively.
M3189 TCN-201 TCN 201 is a NMDA receptor antagonist for NR1/NR2A and NR1/NR2B with pIC50 of 6.8 and 4.3, respectively.
M3126 VU 0357121 VU0357121 is a novel positive allosteric modulator (PAM) of mGlu5 with EC50 of 33 nM, is inactive or very weakly antagonizing at other mGlu receptor subtypes.
M3125 VU 0364770 VU 0364770 is a positive allosteric modulator(PAM) of mGlu4 with EC50 of 1.1 μM, exhibits insignificant activity at 68 other receptors, including other mGlu subtypes.
M3124 VU 0364439 VU 0364439 is a mGlu4 positive allosteric modulator (PAM), with EC50 of 19.8 nM.
M2962 Procyclidine hydrochloride Procyclidine hydrochloride blocks the effects of certain chemicals in the brain, and thus is used to treat Parkinson's disease or extrapyramidal side-effects caused by other medicines.
M2867 MPEP hydrochloride MPEP hydrochloride is a selective mGlu5 receptor antagonist with IC50 of 36 nM, exhibits no appreciable activity at mGlu1b/2/3/4a/7b/8a/6 receptors.
M2766 IEM 1754 dihydrobromide IEM 1754 dihydrobroMide is a selective AMPA/kainate receptor blockers for GluR1 and GluR3 with IC50 of 6 μM.
M2584 MDL-29951 MDL-29951 is a novel glycine antagonist of NMDA receptor activation (Ki=0.14 mM, [3H]glycine binding) in vitro and in vivo with IC50 value of 0.14 mM ([3H]glycine binding).
M2581 Ampalex Ampalex is an ampakine and nootropic that acts as an AMPA receptor positive allosteric modulator which can be used for the research of Alzheimer's disease, schizophrenia and mild cognitive impairment (MCI).




Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.